Evidence map›Paper›PMID 39881262›Full record

Trial reportBMC oral health2025

Clinical performance of class II MOD fiber reinforced resin composite restorations: an 18-month randomized controlled clinical trial.

Mohamed Hamdy Mohamed, Eman Ali Abouauf, Rania Sayed Mosallam

3 registry-linked trialsAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05380973 nacompletednot on this map

Clinical Evaluation of Two Fiber Reinforced Resin Composites Versus Nanohybrid Resin Composite in Posterior Restorations: Randomized Clinical Trial

TypeinterventionalSponsorCairo UniversityRan2023 to 2024Enrolled45ConditionsDental Restoration FailureArmsShort fiber resin composite, Polyethylene ribbon fiber
NCT07285772 nacompletednot on this map

Clinical Performance of Various Bilayer Biomimetic Resin Composite Strategies

TypeinterventionalSponsorTanta UniversityRan2024 to 2025Enrolled40ConditionsComposite Restoration, Composites ResinsArmsshort fiber reinforced composite , long fiber reinforced composite, light cure glass, flowable composite
NCT07496047 nacompletednot on this map

Clinical Evaluation of Short Fiber-Reinforced Composite Restorations With and Without Preheating Approach

TypeinterventionalSponsorTanta UniversityRan2025 to 2026Enrolled70ConditionsComposite Resins, Teeth Sensitivity, Restoration Design, Composite RestorationArmsPreheated everX Posterior composite, Non-preheated everX Posterior composite
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Clinical Performance of Bulk-Fill Versus Incremental Composite Placement Approaches in Vital Posterior Teeth: A 24 Months Randomized Controlled Trial.Journal of esthetic and restorative dentistry : official publication of the American Academy of Esthetic Dentistry ... [et al.] · 2026
    Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mohamed Hamdy MohamedConservative Dentistry Department, Faculty of Dentistry, Cairo University, Cairo, Egypt. mohamed_hamdy@dentistry.cu.edu.eg.
Eman Ali AbouaufConservative Dentistry Department, Faculty of Dentistry, Cairo University, Cairo, Egypt.
Rania Sayed MosallamConservative Dentistry Department, Faculty of Dentistry, Cairo University, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn recent years, there have been suggestions for new restorative strategies that aim to effectively utilize modern adhesive technologies and protect the remaining intact tooth structure. This study was conducted to evaluate the clinical performance of fiber reinforced resin composites in restoring Class II MOD cavities over 18 months.

methodsForty-five participants with class II MOD cavities were randomly enrolled. The participants were allocated to three groups (n = 15): Group (1) short glass fiber reinforced resin composite (EverX Posterior), Group (2) polyethylene fiber (Ribbond-Ultra) reinforced resin composite and Group (3) only conventional resin composite (Filtek Z250). The modified USPHS criteria were used to evaluate the restorations at baseline; and at three, six, 12 and 18 months. The categorical data were reported as frequencies and percentages. Intergroup comparisons were analyzed using Chi-Square test after Bonferroni correction (P ≤ 0.016). Comparisons within each group were analyzed using Cochran's Q test after Bonferroni correction (P ≤ 0.005).

resultsIntergroup comparisons revealed no statistically significant differences in any of the evaluated criteria except for color match. Compared with the other groups, the short glass fiber-reinforced restoration group presented significantly fewer color matches at different follow-up periods.

conclusionsClass II direct fiber-reinforced resin composite restorations can offer acceptable performance similar to the nanohybrid resin composite through 18-month of clinical service. CLINICAL SIGNIFICANCE: Fiber reinforcement of resin composites could be a reliable technique for restoring posterior cavities considering factors such as application complexity, cost and aesthetic considerations.

trial registrationThe trial was registered retrospectively on (19/05/2022) at https://clinicaltrials.gov with the ID (NCT05380973).

Indexed as

Composite ResinsDental Restoration, PermanentAdultColorFemaleGlassHumansMaleMiddle AgedPolyethylenesComposite ResinsEverX PosteriorfiberglassFiltek Z250PolyethylenesRIBBONDClinical performanceEver-X posteriorPolyethylene fiberRibbondShort fiber

Identifiers

PMID39881262
PMCPMC11780895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.